Tabula Rasa HealthCare (NASDAQ:TRHC) and Qiwi (NASDAQ:QIWI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.
Institutional & Insider Ownership
75.2% of Tabula Rasa HealthCare shares are owned by institutional investors. Comparatively, 29.0% of Qiwi shares are owned by institutional investors. 14.0% of Tabula Rasa HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Tabula Rasa HealthCare and Qiwi’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Tabula Rasa HealthCare||$134.55 million||11.19||$14.29 million||($0.04)||-1,859.50|
|Qiwi||$363.00 million||1.50||$53.24 million||$1.04||11.65|
Qiwi has higher revenue and earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than Qiwi, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of recent ratings for Tabula Rasa HealthCare and Qiwi, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Tabula Rasa HealthCare||0||2||10||0||2.83|
Tabula Rasa HealthCare presently has a consensus price target of $71.55, suggesting a potential downside of 3.81%. Qiwi has a consensus price target of $18.00, suggesting a potential upside of 48.51%. Given Qiwi’s higher probable upside, analysts clearly believe Qiwi is more favorable than Tabula Rasa HealthCare.
This table compares Tabula Rasa HealthCare and Qiwi’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Tabula Rasa HealthCare||-16.78%||4.55%||2.37%|
Risk and Volatility
Tabula Rasa HealthCare has a beta of 2.85, meaning that its share price is 185% more volatile than the S&P 500. Comparatively, Qiwi has a beta of 2.8, meaning that its share price is 180% more volatile than the S&P 500.
Qiwi beats Tabula Rasa HealthCare on 8 of the 14 factors compared between the two stocks.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Qiwi Company Profile
Qiwi Plc engages in the provision of payment services through physical, online, and mobile channels. It operates through the following segmentsL Payment Services, Consumer Financial Services, and Corporate and Other Category. The Payment Services segment involves in the virtual distribution services, including QIWI Wallet and applications, payment channels and methods; physical distribution, including kiosks, terminals, and retail points of service, contact money remittance system; and merchant focused services, such as QIWI Cashier or acquiring services. The Consumer Financial Services segment encompasses consumer lending business SOVEST. The Corporate and Other Category segment includes expenses associated with the corporate operations of QIWI Group as well as R&D, projects, and emerging business models. The company was founded on February 26, 2007 and is headquartered in Nicosia, Cyprus.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.